Perth, July 28, 2008 (ABN Newswire) - Stirling Products (ASX:STI) wishes to advise shareholders that its patent application for “the treatment of heaves in horses” with R-salbutamol has now been granted in Australia. The company previously announced that the patent had also been approved in South Africa (ASX, October 10, 2006).
